Philip Liebson to Myocardial Infarction
This is a "connection" page, showing publications Philip Liebson has written about Myocardial Infarction.
Connection Strength
1.070
-
VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
Score: 0.208
-
ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
Score: 0.194
-
ASAP and ANTIBIO. Prev Cardiol. 2003; 6(3):166-8.
Score: 0.194
-
The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis. 1997 Mar-Apr; 39(5):399-444.
Score: 0.129
-
How best to use echocardiography for definitive assessment. Methods of estimating valvular integrity, LV function, pulmonary pressure. J Crit Illn. 1992 May; 7(5):715-28.
Score: 0.093
-
Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy? Prog Cardiovasc Dis. 2002 Jul-Aug; 45(1):49-66.
Score: 0.047
-
Counterpulsation and dobutamine. Their use in treatment of cardiogenic shock due to right ventricular infarct. Arch Intern Med. 1981 Feb; 141(2):247-9.
Score: 0.042
-
Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol. 1999 Jan; 33(1):107-18.
Score: 0.037
-
Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (CAST) experience. Am J Cardiol. 1996 Dec 01; 78(11):1198-201.
Score: 0.032
-
Circadian variations in cardiac disease: clinical implications. Current strategies for preventing MI, dysrhythmias, sudden death. J Crit Illn. 1995 Oct; 10(10):693-6, 699-700, 705-7.
Score: 0.029
-
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993 Nov 24; 270(20):2451-5.
Score: 0.026
-
Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience. J Am Coll Cardiol. 1993 Oct; 22(4):998-1003.
Score: 0.026
-
Acute myocardial infarction diagnosed by myoglobinuria. Arch Intern Med. 1975 Sep; 135(9):1181-3.
Score: 0.007
-
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21; 324(12):781-8.
Score: 0.005
-
The use of noninvasive methods in the evaluation of left ventricular performance in coronary artery disease. I. Relation of systolic time intervals to angiographic assessment of coronary artery disease severity. Am Heart J. 1975 Aug; 90(2):134-44.
Score: 0.002